Navigation Links
Intra-Cellular Therapies Announces the Successful Completion of a Phase Ib/II Study of ITI-007 in Patients with Schizophrenia
Date:7/29/2010

w a personalized approach to patient treatment by making it possible for the first time, to select a clinical dose capable of saturating 5-HT2A receptors while permitting the "dialing in" of an optimal amount of dopamine receptor modulation by simple dose adjustments using a single drug.  At low doses, ITI-007 improves sleep in patients suffering from insomnia characterized by difficulty maintaining sleep throughout the night, without producing daytime sedation.  In contrast to most other antipsychotic medications, ITI-007 is non-sedating, increasing sleep and decreasing wakefulness during the night with no daytime drowsiness or next-day hangover effects.  At higher doses, the ability to optimize the level of dopamine receptor modulation holds promise for the reduction of acute as well as chronic psychotic symptoms in patients with schizophrenia without incurring motor disturbances and other deleterious side effects. Importantly, ITI-007 also has a low propensity, much lower than currently marketed antipsychotic drugs, to bind receptors that mediate deleterious cardiovascular events, profound sedation and rapid and significant weight gain. In addition, the wide separation of affinity at 5-HT2A and D2 receptors may allow for administration of the appropriate amount of dopamine modulation for antipsychotic maintenance therapy and the treatment of bipolar disorder, posttraumatic stress disorder, behavioral disturbances in Alzheimer's disease, and autism. The serotonin reuptake inhibition allows for additional antidepressant efficacy for the treatment of schizoaffective disorder, co-morbid depression, and/or as a stand-alone treatment for major depressive disorder (MDD).

ABOUT INTRA-CELLULAR THERAPIES

Intra-Cellular Therapies, Inc. (ITI) is a biopharmaceutical company developing novel drugs for the treatment of diseases and disorders of the Central Nervous System (CNS).  Building
'/>"/>

SOURCE Intra-Cellular Therapies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Intra-Cellular Therapies Announces the Results of a Phase I PET Study for ITI-007 for the Treatment of Schizophrenia and Other Psychiatric Disorders
2. Intra-Cellular Therapies Announces Successful Outcome of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia
3. Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007
4. Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007/ITI-722
5. Intra-Cellular Therapies Presents Data on Its Schizophrenia and Cognition in Schizophrenia Programs at the 14th Biennial Winter Workshop on Schizophrenia and Bipolar Disorders
6. Intra-Cellular Therapies Initiates Phase 2 Clinical Trial for Sleep Maintenance Insomnia
7. Intra-Cellular Therapies Presents Preclinical Data From Schizophrenia and Sleep Maintenance Programs
8. Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity
9. Reportlinker Adds Personalized Medicine 2010: Assessing the Opportunities and Challenges in Commercializing Companion Diagnostics and Targeted Therapies
10. TransGenRx Protein Therapeutics Technology to Support Research Related to Protein-Based HDL Therapies at Esperion Therapeutics
11. Drug in New Class of Targeted Therapies Shows Early Promise Against Blood-Related Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... TUCSON, Ariz. , July 22, 2014 /PRNewswire/ ... recipient of a SynCardia temporary Total ... of Rochester,s Strong Memorial Hospital with the Freedom® ... heart. Fontana, a 64-year-old retiree from ... disease—cardiomyopathy—for decades. He managed the condition with medications, ...
(Date:7/22/2014)... 22, 2014 The Intellectual ... , the world,s leading provider of intelligent ... Cortellis Clinical Trials Intelligence , its ... milestone with the documentation of more than ... with greater and quicker access to critical ...
(Date:7/22/2014)... SHANGHAI , July 22, 2014 WuXi PharmaTech ... biotechnology and medical device R&D outsourcing company with operations in ... States , today announced that it will release financial ... York Stock Exchange closes on Wednesday, August 13, 2014 (which ... earnings release will be available on the investor relations section ...
Breaking Medicine Technology:'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 2'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 3Thomson Reuters Cortellis Clinical Trials Intelligence Reaches Industry Milestone with 180,000 Clinical Trials 2Thomson Reuters Cortellis Clinical Trials Intelligence Reaches Industry Milestone with 180,000 Clinical Trials 3WuXi PharmaTech Schedules Second-Quarter 2014 Earnings Release 2
(Date:7/22/2014)... Men and women who are fighting ... of their disposable income each year on different retail ... best anti aging products guide to help introduce natural ... is now released and accessible from any tablet, PC ... were selected and inserted into the guide to help ...
(Date:7/22/2014)... July 22, 2014 Print Audit® ... Audit Facilities Manager web portal. Facilities Manager 3.1.0R ... of the software as well as numerous new ... Print Audit Facilities Manager is a powerful, easy ... remotely collect meter reads, automate supplies fulfillment and ...
(Date:7/22/2014)... Ticket Down is a reliable source for ... at Sporting Park in Kansas City, MO. This friendly ... Tickets can be conveniently printed out for this exciting match ... reached toll free at 1-877-870-3653. All tickets for Sporting ... Ticket Down's customer satisfaction guarantee. , About TicketDown.com: , ...
(Date:7/22/2014)... July 22, 2014 Vitamin C is one ... creams mostly marketed to women in the United States. The ... for wrinkles list online for women to review at ... and oils is one way that beauty product manufacturers are ... approach, many companies are using mixtures of Vitamins C, E ...
(Date:7/22/2014)... Recently, iFitDress.com, a popular supplier of wedding dresses and special ... white party dresses to its product category. Additionally, ... available on its website. As a special offer, all customers ... get a discounted rate, up to 54% off. , A ... so its marketing specialist believes the new white party dresses ...
Breaking Medicine News(10 mins):Health News:Best Anti Aging Products Guide Launched for Natural Product Buyers Online at News Portal 2Health News:Print Audit® Releases Facilities Manager 3.1.0R 2Health News:Sporting Kansas City vs. Manchester City Tickets: Ticket Down Has Slashed Ticket Prices for Manchester City vs. Sporting Kansas City on July 23rd 2Health News:Best Vitamin C Serum for Wrinkles List Complied for Women at Consumer News Portal Online 2Health News:Elegant White Party Dresses Now Provided by Distinguished Company iFitDress.com 2
... , March 10 Smart Balance, Inc. (Nasdaq: SMBL ) announced today that Stephen Hughes , Chairman and Chief Executive Officer of Smart Balance, ... Tuesday, March 16, 2010 . , ... , , ... ...
... technological revolution, the "light fantastic" continues to impact people,s ... and performing intricate surgery. As the golden anniversary of ... 7th, Chemical & Engineering News (C&EN), ACS, weekly newsmagazine, ... exciting future of this amazing invention. C&EN ...
... may someday extend men,s lives, , WEDNESDAY, March 10 ... in treating late-stage prostate cancer, it often results in ... to such therapy. , Now, however, researchers working with ... the secondary tumors gain their resistance -- a finding ...
... ... investment banking and business development to LeveragePoint,s Board of Directors. , ... Cambridge, MA (PRWEB) March 10, ... Value Management software for marketing and sales, today announced that entrepreneurial advisor and seasoned ...
... ... ... , , , , ... ...
... , ... ... , , , ... ...
Cached Medicine News:Health News:Smart Balance to Present at Roth Growth Stock Conference 2Health News:Scientists Find Key to Hormone-Resistant Prostate Tumors 2Health News:Scientists Find Key to Hormone-Resistant Prostate Tumors 3Health News:Peyton Marshall Joins LeveragePoint Innovations Board 2Health News:Peyton Marshall Joins LeveragePoint Innovations Board 3Health News:Maryland Legislation Introduced to Prohibit Indoor Tanning for Minors 2Health News:Maryland Legislation Introduced to Prohibit Indoor Tanning for Minors 3Health News:Maryland Legislation Introduced to Prohibit Indoor Tanning for Minors 4Health News:Maryland Legislation Introduced to Prohibit Indoor Tanning for Minors 5Health News:Maryland Legislation Introduced to Prohibit Indoor Tanning for Minors 6Health News:Celebrate National Nutrition Month and St. Patrick's Day, Go Green With Pistachios - The Only Green Nut! 2Health News:Celebrate National Nutrition Month and St. Patrick's Day, Go Green With Pistachios - The Only Green Nut! 3Health News:Celebrate National Nutrition Month and St. Patrick's Day, Go Green With Pistachios - The Only Green Nut! 4Health News:Celebrate National Nutrition Month and St. Patrick's Day, Go Green With Pistachios - The Only Green Nut! 5
... is designed for the treatment of diaphyseal ... preformed design provides post operative support following ... or external fixation. The brace allows for ... fracture site, increasing vascularity and encouraging bone ...
The UltraLite Post Op Brace provides a fixed or range of motion control. The UltraLite Post Op Brace indications include: , Post knee trauma , Peri-operative use , Conservative management of isolated...
... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...
... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
Medicine Products: